Received Jul 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
received a 1st dose of Engerix-B 2 months ago, she is late for her second dose/missed dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 55-year-old female patient who did not receive HBV (Engerix B) for prophylaxis. Previously administered products included Engerix B (received 1st dose on 7th May 2025, Batch number: 4BX39 and Expiry date: 29-JUL-2027). On an unknown date, the patient did not receive the 2nd dose of Engerix B. The patient experienced incomplete course of vaccination (Verbatim: received a 1st dose of Engerix-B 2 months ago, she is late for her second dose/missed dose). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date:17-JUL-2025 The reporter called to know how to proceed for a second late dose of Engerix-B. Patient was coming on 17th July 2025 to receive her second dose. The reporter wanted to know when they could administer the third dose. The reporter consented to follow up. Till the time of reporting, the patient did not receive the 2nd dose of Engerix B, which led to incomplete course of vaccination.